157
Views
27
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Antibiotic administration in patients with preterm premature rupture of membranes reduces the rate of histological chorioamnionitis: a prospective, randomized, controlled study

, , , , , & show all
Pages 35-41 | Published online: 07 Jul 2009

References

  • Ovalle A, Martinez MA, Poblete JP, et at. Microbiology of preterm premature rupture of the membranes: relationship with maternal and neonatal morbidity and the rupture of membranes-delivery interval. Rev Chile Obstet Ginecol 1995; 60:252–62
  • Ovalle A, Martinez MA, Kakarieka ME, et at. Placental histopathology in premature rupture of membranes. Its rela-tionship with microbiological findings, maternal, and neo-natal outcome. Rev Med Chile 1998;126:911–18
  • Yoon BH, Romero R, Park JS, et at. Fetal exposure to an intra-amniotic inflammation and development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182:675–81
  • Górnez R, Romero R, Ghezzi F, et at. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194–202
  • Mercer B, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet 1995;346:1271–9
  • Miller JM, Brazy JE, Gall SA, et at. Premature rupture of the membranes: maternal and neonatal infectious morbidity related to betamethasone and antibiotic therapy. J Reprod Med 1980;25:173–6
  • Morales WJ, Angel JL, O'Brien WF, et at. Use of ampic ill in and corticosteroids in premature rupture of the membranes: a randomized study. Obstet Gynecol 1989;73:721–6
  • Johnston MM, Sanchez-Ramos L, Vaughn AJ, et at. Antibiotic therapy in preterm premature rupture of membranes: a randomized prospective, double blind trial. Am J Obstet Gynecol 1990;163:743–7
  • Owen J, Groome LJ, Hauth J. Randomized trial of p rophylact ic therapy after preterm amnion rupture. Am J Obstet Gynecol 1993;169:976–81
  • Ernest JM, Givner LB. A prospective, randomized, placebo-controlled trial of penicillin in preterm premature rupture of membranes. Am J Obstet Gynecol 1994;170:516–21
  • Ovalle A, Martinez MA, Górnez R, et at. Antibiotic therapy in patients with preterm premature rupture of membranes: a prospective, randomized, placebo controlled study with microbiologic assessment of the amniotic cavity and lower genital tract. Prenat Neonat Med 1997;2:213–22
  • Mercer BM, Miodovnik M, Thurnau GR, et at. Antibiotic therapy for reduction of infant morbidity after preterm pre-mature rupture of membranes. J Am Med Assoc 1997;278: 989–95
  • MercerBM. Antibiotic therapy for preterm premature rupture of membranes. Clin Obstet Gynecol 1998;41:461�8
  • Garc�a-Burguillo A, Hern�ndez-Garc�a JM, de la Fuente P. Profilaxis con eritromicina en gestaciones de pret�rmino con rotura prematura de las membranas amni�ticas. Clin Invest Ginecol Obstet 1996;3:96�100
  • Cox SM, Leveno KJ, ShermanML, et al. Rupturedmembranes at 24 to 29 weeks: a randomized double blind trial of antimicrobials versus placebo. Am J Obstet Gynecol 1995;172: 412�16
  • McGregor JA, French JI, Seo K. Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double-blind, placebo-controlled trial of erythromycin. Am J Obstet Gynecol 1991;165:632�40
  • Mercer BM, Moretti ML, Prevost RR, et al. Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients. Am J Obstet Gynecol 1992;166:794�802
  • Lockwood CJ, Costigan K, Ghidini A, et al. Double-blind, placebo-controlledtrial of piperacillinprophylaxis in preterm membranes rupture. Am J Obstet Gynecol 1993;169:970�6
  • Amon E, Lewis SV, Sibai BM, et al. Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol 1988;159:539�43
  • Stamm WE, Harrison HR, Alexander ER, et al. Diagnosis of Chlamydia trachomatis infections by directinmunofluorescence staining of genital secretions. Ann Int Med 1984;101:638�41
  • Smith TF, Weed LA, Pettersen GR, et al. Recovery of Chlamydia and genital mycoplasma transported in sucrose phosphate buffer and urease color test medium. Health Lab Sci 1977;14:30�4
  • Wang E, Richardson H.A rapidmethod for detectionof group B streptococcal colonization: testing at the bedside. Obstet Gynecol 1990;76:882�5
  • Villagra E, Martinez MA, Ovalle A. Flora microbiana genital en una poblaci�n de alto riesgo obst�trico. Rev Chile Obstet Ginecol 1994;59:32�8
  • Balows A, Hausler W, Hermann K, et al., eds. Manual of Clinical Microbiology, 5th edn. Washington DC: American Society For Microbiology, 1991
  • Taylor-Robinson D, Furr PM. Recovery and identification of genital tract Mycoplasmas. Israel J Med Sci 1981;17:648�53
  • Nugent R, Krohn M, Hillier S. Reliability of diagnosing bacterial vaginosis is improved by standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297�301
  • Romero R, Mazor M, Morrotti R, et al. Microbial invasion of the amniotic cavity in spontaneous rupture of membranes at term. Am J Obstet Gynecol 1992;166:129�33
  • McGregorJA, French JI, JonesW, et al. Associationof cervicovaginal infections with increased vaginal fluid phospholipase A2 activity.Am J Obstet Gynecol 1992;167:1588�94
  • Gibbs RS, Castillo MS, Rogers PJ. Management of acute chorioamnionitis. Am J Obstet Gynecol 1980;136:109�13
  • Bernischke K, Kaufman P. Pathology of the Human Placenta. New York: Springer Verlag, 2001:419�34, 591�659
  • Perrin VDK. Placenta as a reflection of maternal disease. In Pathology of the Placenta. New York: Churchill Livingstone, 1984:57�70
  • Fox H. Histologicalabnormalitiesof the placenta. In Pathology of the Placenta. Philadelphia,PA:WBSaunders,1978:149�97
  • KeelingJW. Placenta and umbilical cord. In Fetal and Neonatal Pathology. Berlin: Springer-Verlag, 1987:45�67
  • Van HoevenKH,AnyaegbunamA, Hochster H, et al. Clinical significance of increasing histologic severity of acute inflammation in the fetal membranes and umbilical cord. Pediatr Pathol 1996;16:731�44
  • McGregor JA, French JI, Parker R, et al. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospectivecontrolled evaluation. Am J Obstet Gynecol 1995;173:157�67

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.